User login

Hatch Continues To Take Hard Line On Data Exclusivity For Biologics In TPP

July 29, 2015 at 4:41 PM
Senate Finance Committee Chairman Orrin Hatch (R-UT) this Monday (July 27) reiterated his demand that a final Trans-Pacific Partnership (TPP) deal require 12 years of data exclusivity for biologic medicines, following reports that TPP countries might settle on seven or eight years instead. "It’s imperative this trade pact have the strongest possible terms for innovative industries. This means twelve years of regulatory data protection for biologics and strong copyright and trademark protections," Hatch said in a video message addressed to...

Not a subscriber? You can request 30 days free access to exclusive, behind-the-scenes reporting on trade policy in the Biden era.